Henry Schein (HSIC) & Cantel Medical Corp. (CMD) Head to Head Survey

Cantel Medical Corp. (NYSE: CMD) and Henry Schein (NASDAQ:HSIC) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitabiliy, dividends, earnings, analyst recommendations, valuation and risk.

Analyst Recommendations

This is a summary of recent recommendations for Cantel Medical Corp. and Henry Schein, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cantel Medical Corp. 0 3 0 0 2.00
Henry Schein 0 10 5 0 2.33

Cantel Medical Corp. presently has a consensus target price of $100.00, indicating a potential upside of 31.58%. Henry Schein has a consensus target price of $180.54, indicating a potential downside of 2.16%. Given Cantel Medical Corp.’s higher possible upside, research analysts clearly believe Cantel Medical Corp. is more favorable than Henry Schein.

Dividends

Cantel Medical Corp. pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Henry Schein does not pay a dividend. Cantel Medical Corp. pays out 8.3% of its earnings in the form of a dividend.

Insider & Institutional Ownership

83.4% of Cantel Medical Corp. shares are held by institutional investors. Comparatively, 90.7% of Henry Schein shares are held by institutional investors. 14.9% of Cantel Medical Corp. shares are held by insiders. Comparatively, 1.3% of Henry Schein shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Risk & Volatility

Cantel Medical Corp. has a beta of 1.24, indicating that its share price is 24% more volatile than the S&P 500. Comparatively, Henry Schein has a beta of 1.09, indicating that its share price is 9% more volatile than the S&P 500.

Profitability

This table compares Cantel Medical Corp. and Henry Schein’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Cantel Medical Corp. 9.50% 17.75% 11.32%
Henry Schein 4.53% 19.74% 8.42%

Valuation and Earnings

This table compares Cantel Medical Corp. and Henry Schein’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Cantel Medical Corp. $741.62 million 4.25 $141.91 million $1.69 44.97
Henry Schein $11.78 billion 1.24 $1.00 billion $6.58 28.04

Henry Schein has higher revenue and earnings than Cantel Medical Corp.. Henry Schein is trading at a lower price-to-earnings ratio than Cantel Medical Corp., indicating that it is currently the more affordable of the two stocks.

Cantel Medical Corp. Company Profile

Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies. The Company’s Water Purification and Filtration segment includes water purification equipment and services, filtration and separation products, and disinfectant, sterilization and decontamination products and services. Its Healthcare Disposables segment includes single-use, infection prevention and control healthcare products. The Company’s Dialysis segment includes medical device reprocessing systems, sterilants/disinfectants, dialysate concentrates and other supplies for renal dialysis. The Company offers a range of filters utilizing hollow fiber membrane technology.

Henry Schein Company Profile

Henry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The technology and value-added services segment provides software, technology and other value-added services to healthcare practitioners. Its technology group offerings include practice management software systems for dental and medical practitioners and animal health clinics. The Company provides its services to dental practitioners and laboratories, animal health clinics and physician practices, as well as government and institutional healthcare clinics.

Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
Shares at Radius Jump as Bone Drug of Amgen Has Setback
Shares at Radius Jump as Bone Drug of Amgen Has Setback


Leave a Reply

© 2006-2017 Ticker Report. Google+.